The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
| dc.contributor.author | Lång Maarit | |
| dc.contributor.author | Jakob Stephan M. | |
| dc.contributor.author | Takala Riikka | |
| dc.contributor.author | Lyngbakken Magnus N. | |
| dc.contributor.author | Turpeinen Anu | |
| dc.contributor.author | Omland Torbjörn | |
| dc.contributor.author | Merz Tobias M. | |
| dc.contributor.author | Wiegand Jan | |
| dc.contributor.author | Grönlund Juha | |
| dc.contributor.author | Rahi Melissa | |
| dc.contributor.author | Valtonen Mika | |
| dc.contributor.author | Koivisto Timo | |
| dc.contributor.author | Rösjö Helge | |
| dc.contributor.author | Bendel Stepani | |
| dc.contributor.organization | fi=anestesiologia ja tehohoito|en=Anaesthesiology, Intensive Care| | |
| dc.contributor.organization | fi=kliiniset neurotieteet|en=Clinical Neurosciences| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.74845969893 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.82197219338 | |
| dc.converis.publication-id | 178033945 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/178033945 | |
| dc.date.accessioned | 2025-08-28T00:36:46Z | |
| dc.date.available | 2025-08-28T00:36:46Z | |
| dc.description.abstract | <p>Subarachnoid hemorrhage (SAH) is a serious condition, and a myocardial injury or dysfunction could contribute to the outcome. We assessed the prevalence and prognostic impact of cardiac involvement in a cohort with SAH. This is a prospective observational multicenter study. We included 192 patients treated for non-traumatic subarachnoid hemorrhage. We performed ECG recordings, echocardiographic examinations, and blood sampling within 24 h of admission and on days 3 and 7 and at 90 days. The primary endpoint was the evidence of cardiac involvement at 90 days, and the secondary endpoint was to examine the prevalence of a myocardial injury or dysfunction. The median age was 54.5 (interquartile range [IQR] 48.0–64.0) years, 44.3% were male and the median World Federation of Neurological Surgeons (WFNS) score was 2 (IQR 1–4). At day 90, 22/125 patients (17.6%) had left ventricular ejection fractions ≤ 50%, and 2/121 patients (1.7%) had evidence of a diastolic dysfunction as defined by mitral peak E-wave velocity by peak eʹ velocity (E/eʹ) > 14. There was no prognostic impact from echocardiographic evidence of cardiac complications on neurological outcomes. The overall prevalence of cardiac dysfunction was modest. We found no demographic or SAH-related factors associated with 90 days cardiac dysfunction.<br></p> | |
| dc.identifier.eissn | 2045-2322 | |
| dc.identifier.jour-issn | 2045-2322 | |
| dc.identifier.olddbid | 206041 | |
| dc.identifier.oldhandle | 10024/189068 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/40655 | |
| dc.identifier.url | https://www.nature.com/articles/s41598-022-24675-8 | |
| dc.identifier.urn | URN:NBN:fi-fe202301255506 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Takala, Riikka | |
| dc.okm.affiliatedauthor | Grönlund, Juha | |
| dc.okm.affiliatedauthor | Rahi, Melissa | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.discipline | 3121 Internal medicine | en_GB |
| dc.okm.discipline | 3121 Sisätaudit | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | NATURE PORTFOLIO | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.articlenumber | 20109 | |
| dc.relation.doi | 10.1038/s41598-022-24675-8 | |
| dc.relation.ispartofjournal | Scientific Reports | |
| dc.relation.issue | 1 | |
| dc.relation.volume | 12 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/189068 | |
| dc.title | The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage | |
| dc.year.issued | 2022 |
Tiedostot
1 - 1 / 1